PKTX · ProtoKinetix, Inc.
What's happening
- PKTX is down 25.00% today, trading at $0.00. — Live quote
- It's trading within 3% of its 52-week low ($0.00). (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-07-31. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-K, filed 2026-09-03; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -48.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PKTX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | -$84.9K | -$91.1K | -$97.7K | -$84.6K | -$85.1K | -$92.0K | -$80.4K | -$115.6K |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 |
| EPS (basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 |
Balance sheet
| Line item | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $483.4K | $477.6K | $474.4K | $528.6K | $466.1K | $479.3K | $473.5K | $461.4K |
| Total liabilities | — | — | — | — | — | — | — | — |
| Stockholders' equity | $297.9K | $250.4K | $325.3K | $376.4K | $342.1K | $391.5K | $414.8K | $393.8K |
| Total current assets | — | — | — | — | — | $6.7K | $3.2K | $3.9K |
| Total current liabilities | $185.4K | $227.2K | $149.1K | $152.2K | $124.0K | $87.7K | $58.8K | $67.6K |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Intangible assets | $481.2K | $476.0K | $473.3K | $478.1K | $469.8K | $472.5K | $470.3K | $457.5K |
| Accounts payable | $185.4K | $227.2K | $149.1K | $152.2K | $124.0K | $87.7K | $58.8K | $67.6K |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $2.2K | $2.1K | $2.1K | $2.1K | $2.0K | $2.0K | $1.9K | $1.9K |
| Retained earnings | -$48.6M | -$48.5M | -$48.4M | -$48.3M | -$48.2M | -$48.1M | -$48.0M | -$48.0M |
Cash flow
| Line item | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $558 | -$3.9K | -$80.1K | -$52.0K | -$45.2K | -$39.1K | -$80.9K | -$57.8K |
| Investing cash flow | -$20.0K | -$5.6K | -$4.8K | -$25.9K | -$5.1K | -$17.4K | -$25.8K | -$9.7K |
| Financing cash flow | $20.0K | $10.0K | $35.5K | $132.0K | $40.0K | $60.0K | $106.0K | $50.0K |
| Share-based compensation | $0 | $0 | — | — | $5.4K | $1.4K | — | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | -$393.6K | -$364.2K | -$415.5K | -$1.9M | -$2.3M |
| EPS (diluted) | $0.00 | $0.00 | $-0.01 | $-0.01 | — |
| EPS (basic) | $0.00 | $0.00 | $-0.01 | $-0.01 | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $483.4K | $466.1K | $480.6K | $462.9K | $446.2K |
| Total liabilities | — | — | — | — | — |
| Stockholders' equity | $297.9K | $342.1K | $435.9K | $421.3K | $353.0K |
| Total current assets | — | — | $21.5K | $26.6K | $83.6K |
| Total current liabilities | $185.4K | $124.0K | $44.7K | $41.5K | $93.3K |
| Cash & equivalents | — | — | — | — | $57.6K |
| Accounts receivable | — | — | — | — | — |
| Intangible assets | $481.2K | $469.8K | $459.1K | $436.3K | $362.7K |
| Accounts payable | $185.4K | $124.0K | $44.7K | $41.5K | $93.3K |
| Accrued liabilities | — | — | — | — | — |
| Short-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $2.2K | $2.0K | $1.9K | $1.7K | $1.6K |
| Retained earnings | -$48.6M | -$48.2M | -$47.9M | -$47.4M | -$45.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$135.4K | -$223.1K | -$376.0K | -$804.7K | -$889.9K |
| Investing cash flow | -$56.3K | -$58.1K | -$59.2K | -$132.0K | -$91.0K |
| Financing cash flow | $197.5K | $256.0K | $430.0K | $904.7K | $845.0K |
| Share-based compensation | $0 | $5.4K | $0 | $1.1M | $1.4M |
| Change in accounts receivable | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PKTX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2021-12-22 to 2024-09-26
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SMITH CLARENCE EDWARD | President & CEO | Open market purchase | 2024-09-26 | 2,000,000 |
| Guzzetta Michael Richard | CFO | Open market purchase | 2023-10-26 | 20,000 |
| Young Lachlan Grant | 10% owner | Other acquisition/disposition | 2022-12-13 | 1,125,600 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:49 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-03 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-06-17 | 8-K | 2026-03-31 | View on SEC.gov → |
| 2025-11-21 | 8-K | 2025-11-21 | View on SEC.gov → |
| 2025-11-17 | 8-K | 2025-11-13 | View on SEC.gov → |
| 2025-11-13 | 10-Q | 2025-09-30 | View on SEC.gov → |
| 2025-10-10 | 8-K | 2025-10-06 | View on SEC.gov → |
| 2025-08-13 | 10-Q | 2025-06-30 | View on SEC.gov → |
| 2025-05-15 | 10-Q | 2025-03-31 | View on SEC.gov → |
| 2025-03-28 | 10-K | 2024-12-31 | View on SEC.gov → |
| 2024-11-12 | 10-Q | 2024-09-30 | View on SEC.gov → |
| 2024-09-27 | 4 | 2024-09-26 | View on SEC.gov → |
| 2024-07-30 | 10-Q | 2024-06-30 | View on SEC.gov → |
Recent news
Headlines about PKTX (ProtoKinetix, Inc.). Links open the publisher — we don’t host full articles.
-
ProtoKinetix and IQVIA partner to support development of eye treatment
Seeking Alpha · 2021-05-12
No headlines in this category right now — try “All”.